tadalafil has been researched along with Heart Disease, Ischemic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornelius, V; Hazell, L; Shakir, SA; Wilton, LV | 1 |
| Ahmad, N; Ali, AK; Ashraf, M; Wang, Y | 1 |
| Bedding, A; Braat, S; Effron, M; Emmick, J; Kloner, R; MacDonald, T; Mitchell, M; Patterson, D; Warner, M | 1 |
| Boshier, A; Harris, S; Hazell, L; Shakir, SA; Wilton, LV | 1 |
1 trial(s) available for tadalafil and Heart Disease, Ischemic
| Article | Year |
|---|---|
The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.
Topics: Aged; Analysis of Variance; Blood Pressure; Carbolines; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Phosphodiesterase Inhibitors; Tadalafil; Vasodilator Agents | 2005 |
3 other study(ies) available for tadalafil and Heart Disease, Ischemic
| Article | Year |
|---|---|
The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.
Topics: Adult; Aged; Aged, 80 and over; Carbolines; Cohort Studies; England; Erectile Dysfunction; Humans; Male; Middle Aged; Myocardial Ischemia; Phosphodiesterase Inhibitors; Product Surveillance, Postmarketing; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires; Tadalafil | 2009 |
Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury.
Topics: Animals; Blotting, Western; Carbolines; Cardiotonic Agents; In Situ Nick-End Labeling; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Myocardium; Oncogene Protein v-akt; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Phosphorylation; Tadalafil; Ventricular Function, Left | 2009 |
An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.
Topics: Aged; Carbolines; Cohort Studies; England; Erectile Dysfunction; Family Practice; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Phosphodiesterase Inhibitors; Surveys and Questionnaires; Tadalafil | 2007 |